Compare BCV & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCV | APYX |
|---|---|---|
| Founded | 1971 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.4M | 128.0M |
| IPO Year | N/A | 1995 |
| Metric | BCV | APYX |
|---|---|---|
| Price | $22.13 | $3.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 10.1K | ★ 100.5K |
| Earning Date | 01-01-0001 | 03-10-2026 |
| Dividend Yield | ★ 8.13% | N/A |
| EPS Growth | N/A | ★ 19.40 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.92 |
| Revenue Next Year | N/A | $10.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.63 | $0.83 |
| 52 Week High | $24.55 | $4.50 |
| Indicator | BCV | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 44.16 | 57.77 |
| Support Level | $21.88 | $3.82 |
| Resistance Level | $22.72 | $4.32 |
| Average True Range (ATR) | 0.49 | 0.29 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 38.78 | 76.42 |
Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.